-
Purdue Pharma, states reach $6B settlement deal: 5 notes
The Sackler family, owners of OxyContin maker Purdue Pharma, has agreed to pay $6 billion to settle long-running litigation alleging they fueled the nation's opioid epidemic, The New York Times reported March 3. -
Black overdose deaths surpass white deaths for 1st time in 20 years: 4 study findings
The overdose mortality rate among Black Americans in 2020 was higher than that of white Americans for the first time since 1999, according to a March 2 research letter published in JAMA Psychiatry. -
J&J, 3 drug wholesalers reach $26B opioid settlement
Four large U.S. corporations will pay $26 billion to settle lawsuits alleging their business practices fueled the opioid epidemic, NPR reported last week. -
CDC proposes less stringent opioid prescribing guidelines
The CDC on Feb. 10 proposed new opioid prescribing guidelines that eliminate the recommended dose ceilings for chronic pain patients. -
J&J, 3 wholesalers reach $590M opioid settlement with Native American tribes
AmerisourceBergen, McKesson, Cardinal Health and Johnson & Johnson reached a $590 million deal to settle lawsuits filed by hundreds of Native American tribes alleging the companies fueled the opioid crisis, according to a Feb. 1 NPR report. -
American youth lost 1.2M years of life to overdoses in 5 years, study shows
American adolescents and young adults lost an estimated 1.2 million years of life due to unintentional drug overdoses from 2015-19, according to a study published Jan. 31 in JAMA. -
Opioid overdose deaths surge among older adults, study shows
The opioid epidemic has not spared older Americans, as overdose deaths among Americans ages 55 and older have steadily increased from 1999-2019, according to a study published Jan. 11 in JAMA Network Open. -
NYC to dispense naloxone, syringes via vending machines
New York City will install public health vending machines in 10 locations across the city to combat the opioid crisis, The Hill reported Jan. 3. -
Reducing Perioperative Exposure to Opioid Analgesics
Presented at 2021 ASA Annual Meeting in San Diego, CA (October 2021) Background The narcotic crisis in the United States has claimed nearly 850,000 lives since 1999 with a staggering annual mortality rate of approximately 70,000 lives. An overwhelming majority of overdose-related deaths in 2017 involved an opioid, and of the 10 million Americans that misused opioids in 2018, over 90% misused prescription pain medications. -
Judge tosses Purdue Pharma's $4.5B opioid settlement
A federal judge on Dec. 16 reversed Purdue Pharma's $4.5 billion opioid settlement, saying members of the Sackler family could not be granted legal immunity from other opioid lawsuits. -
Fentanyl overdose deaths rising in the US, CDC report finds
Overdose deaths involving illicitly manufactured fentanyls increased sharply from July 2019 to December 2020 in certain regions of the U.S., according to the CDC's Dec. 14 Morbidity and Mortality Weekly Report. -
Allergan settles New York opioid case for $200M
Allergan agreed to pay $200 million by mid-2022 to settle allegations that it contributed to New York's opioid epidemic, state Attorney General Letitia James announced Dec. 8. -
CVS, Walgreens and Walmart contributed to Ohio's opioid crisis, jury rules
CVS Health, Walmart and Walgreens substantially contributed to the opioid crisis in two Ohio counties, a federal jury ruled Nov. 23, according to The New York Times. -
Comprehensive approach to opioid use disorder treatment lacking in most states, study says
Governments at the federal and state levels established opioid use disorder treatment programs during the pandemic, but few states took a comprehensive approach to treating the condition, according to a study published Nov. 19 in JAMA Health Forum. -
More than 100,000 Americans died of overdoses in 1 year, federal data shows
More than 100,000 Americans died of overdoses in the 12-month period that ended in April, The New York Times reported Nov. 17. -
Bloomberg Philanthropies pledges $120M to combat overdose deaths
Bloomberg Philanthropies, the philanthropy company of billionaire Michael Bloomberg, said Nov. 10 it plans to invest $120 million over five years to fight opioid overdoses in five states. -
Oklahoma Supreme Court reverses $465M opioid ruling against J&J
The Oklahoma Supreme Court reversed a lower court ruling Nov. 9 that would have required Johnson & Johnson to pay the state $465 million to address its role in the opioid epidemic, The New York Times reported. -
DEA takes hard stance on pharmacies administering buprenorphine
The Drug Enforcement Administration's approach to buprenorphine regulation is exacerbating the opioid epidemic by unnecessarily discouraging pharmacies from dispensing the drug, pharmacists and harm reduction experts told NPR on Nov. 8. -
Congress looking into McKinsey's work with opioid makers
Congress launched an investigation Nov. 5 into global consulting firm McKinsey's work with opioid manufacturers, The New York Times reported. -
Uncovering A Crucial Arrow in the Quiver to Fight Opioid Overdoses
A revolution is quietly underway in the treatment of opioid addiction via the combination of medication-assisted treatment (MAT) and telemedicine. This innovative treatment, called teleMAT, takes traditional MAT to the next level. How? By making it easy to reach a physician proficient in addiction treatment while also avoiding the social stigma of being seen entering a doctor’s office.
Page 3 of 50